CSL Seqirus partnership expanded; UK to introduce AUJEMFLU (aTIVc)
CSL Seqirus says it has strengthened its partnership with the UK Government, with the UK set to be the first country to introduce AUJEMFLU (adjuvanted cell-based) flu vaccine (aTIVc) and an extended health security pandemic agreement.